216 related articles for article (PubMed ID: 32741542)
1. Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
Park JY; Chong GO; Park JY; Chung D; Lee YH; Lee HJ; Hong DG; Han HS; Lee YS
Gynecol Oncol; 2020 Oct; 159(1):157-163. PubMed ID: 32741542
[TBL] [Abstract][Full Text] [Related]
2. Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.
Zhang X; Lv Z; Xu X; Yin Z; Lou H
BMC Cancer; 2020 Jul; 20(1):664. PubMed ID: 32678039
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral budding: A novel prognostic biomarker for tumor recurrence and a potential predictor of nodal metastasis in uterine cervical cancer.
Chong GO; Jee-Young Park N; Han HS; Cho J; Kim MG; Choi Y; Yeo JY; Lee YH; Hong DG; Park JY
Eur J Surg Oncol; 2021 Dec; 47(12):3182-3187. PubMed ID: 34284905
[TBL] [Abstract][Full Text] [Related]
4. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
5. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
7. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
8. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
9. High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence Risk.
Huang B; Cai J; Xu X; Guo S; Wang Z
PLoS One; 2016; 11(11):e0166311. PubMed ID: 27861522
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
Metindir J; Bilir G
Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
[TBL] [Abstract][Full Text] [Related]
11. Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study.
Casarin J; Buda A; Bogani G; Fanfani F; Papadia A; Ceccaroni M; Malzoni M; Pellegrino A; Ferrari F; Greggi S; Uccella S; Pinelli C; Cromi A; Ditto A; Di Martino G; Anchora LP; Falcone F; Bonfiglio F; Odicino F; Mueller M; Scambia G; Raspagliesi F; Landoni F; Ghezzi F
Gynecol Oncol; 2020 Oct; 159(1):164-170. PubMed ID: 32665147
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
[TBL] [Abstract][Full Text] [Related]
13. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
14. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
15. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
Kim SI; Kim JY; Wee CW; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Park NH; Song YS; Kim TH
BMC Cancer; 2021 Nov; 21(1):1260. PubMed ID: 34809599
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
Nanthamongkolkul K; Hanprasertpong J
Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]